Key result
5-AIQ before resuscitation reduces organ injury but fails to improve circulatory failure in hemorrhagic shock.
Why the study?
Poly (ADP-ribose) synthetase (PARP) activation contributes to organ injury and dysfunction caused by haemorrhagic shock, and the effects of a potent water-soluble PARP inhibitor on this injury were investigated.
The PARP inhibitor 5-AIQ reduces multiple organ injury and dysfunction following haemorrhagic shock and resuscitation in a rat model.
5-AIQ attenuates multiple organ injury in rat hemorrhagic shock; hypothesis-generating for PARP inhibition in human resuscitation, warranting clinical trials.
Poly (ADP-ribose) synthetase (PARP) is a nuclear enzyme activated by strand breaks in DNA, which are caused inter alia by reactive oxygen species (ROS). Here we report on (i) a new synthesis of a water-soluble and potent PARP inhibitor, 5-aminoisoquinolinone (5-AIQ) and (ii) investigate the effects of 5-AIQ on the circulatory failure and the organ injury/dysfunction caused by haemorrhage and resuscitation in the anaesthetized rat. Exposure of human cardiac myoblasts (Girardi cells) to hydrogen peroxide (H(2)O(2), 3 mM for 1 h, n=9) caused a substantial increase in PARP activity. Pre-treatment of these cells with 5-AIQ (1 microM - 1 mM, 10 min prior to H(2)O(2)) caused a concentration-dependent inhibition of PARP activity (IC(50): approximately 0.01 mM, n=6). Haemorrhage and resuscitation resulted (within 4 h after resuscitation) in a delayed fall in blood pressure (circulatory failure) as well as in rises in the serum levels of (i) urea and creatinine (renal dysfunction), (ii) aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl-transferase (gamma-GT) (liver injury and dysfunction), (iii) lipase (pancreatic injury) and (iv) creatine kinase (CK) (neuromuscular injury) (n=10). Administration (5 min prior to resuscitation of 5-AIQ) (0.03 mg kg(-1) i.v., n=8, or 0.3 mg kg(-1) i.v., n=10) reduced (in a dose-related fashion) the multiple organ injury and dysfunction, but did not affect the circulatory failure, associated with haemorrhagic shock. Thus, 5-AIQ abolishes the multiple organ injury caused by severe haemorrhage and resuscitation.
No takes yet. Share an insight, caveat, or question.
McDonald et al. (2000) studied Haemorrhagic shock and organ injury. 5-aminoisoquinolinone (5-AIQ) vs. Control was evaluated on Multiple organ injury and dysfunction markers. Administration of 5-AIQ prior to resuscitation reduced multiple organ injury and dysfunction in a dose-related fashion, but did not affect circulatory failure associated with haemorrhagic shock.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: